Evidence map›Paper›PMID 25044800›Full record

ReviewChembiochem : a European journal of chemical biology2014

Therapeutic applications of an expanded genetic code.

Sophie B Sun, Peter G Schultz, Chan Hyuk Kim

Open access · greenAbstract readReview
In one paragraph

Review in Chembiochem : a European journal of chemical biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. General lack of structural characterization of chemically synthesized long peptides.Protein science : a publication of the Protein Society · 2019
    Review
  17. Article
  18. Review
  19. Playing with the Molecules of Life.ACS chemical biology · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sophie B SunCalifornia Institute for Biomedical Research, 11119 North Torrey Pines Road, Suite 100, La Jolla, CA 92037 (USA).
Peter G Schultz
Chan Hyuk Kim
California Institute for Biomedical Research · US

Funding

IN VIVO INCORPORATION OF UNNATURAL AMINO ACIDSR01GM062159 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SCHULTZ, PETER G · 2001 to 2022
$8.2M
Ribosomal Synthesis of Peptides with Unnatural Building BlocksR01GM097206 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SCHULTZ, PETER G · 2011 to 2014
$1.4M
NIGMS NIH HHS R01 GM062159NIGMS NIH HHS R01 GM097206
6 · The paper itself

Abstract

To date, over 100 noncanonical amino acids (ncAAs) have been genetically encoded in living cells in order to expand the functional repertoire of the canonical 20 amino acids. More recently, this technology has been expanded to the field of protein therapeutics, where traditional chemical methods typically result in heterogeneous mixtures of proteins. The site-specific incorporation of ncAAs with orthogonal chemical groups allows unprecedented control over the site of conjugation and the stoichiometry, thus facilitating the rational optimization of the biological functions and/or pharmacokinetics of biologics. Herein, we discuss the recent contribution of ncAA technology in enhancing the pharmacological properties of current protein therapeutics as well as developing novel therapeutic modalities.

Indexed as

Genetic CodeAmino AcidsHumansProteinsAmino AcidsProteinsantibody-drug conjugatesbispecific antibodiesclick chemistrynoncanonical amino acidstherapeutic proteins

Identifiers

PMID25044800
PMCPMC4472442
OpenAlexW1967635910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.